ihub mods & admin delete yet another on topic post! No

New Post Public Reply Private Reply Replies (1) Message Board
crookedneck
ihub mods & admin delete yet another on topic post! No matter how I follow the to rules to post, they delete it!

Gotta love it when all the skeptics chime in to try and stir the pot to shake the tree. EVERYTHING that is being posted is based on THEIR ASSUMPTIONS! That is the one FACT you SHOULD remember! It is a clear attempt of trying to make CDNL seem like a scam by using one assumption after another.

When asked to provide supportive material to back up their allegations, all we get are links to things that prove NOTHING! Those links to people from HSVW show a profile with missing data and of course they fill in the blanks by assuming whatever they can dream up.

Then we have the assumptions being made from the fact they can't find the names from the two large companies in China that are involved with this HSVW partnership. They have chosen to remain anonymous by way of a nondisclosure agreement, most likely, which happens all the time in the world of business, yet in this case, it is being made out to mean something fishy. Really?

If that wasn't enough, we have this 12 year old situation regarding a very disgruntled USAR/Vast Mtn shareholder who has plastered things all over the internet and social media, after losing everything they invested in this otc stock. Due to a legal business transaction CDNL conducted with USAR/Vast Mtn to provide a service for a fee, it is being assumed that CDNL is now connected to this securities fraud case against USAR/Vast Mtn from 12 years ago. Given the FACT that CDNL was never implicated, nor even investigated, in this matter, THEY are trying to make other assumptions, as a way to keep THEIR 12+ year struggle against USAR/Vast Mtn alive. It has created a new audience by trying to involve CDNL & get new attention for THEIR attack campaign against USAR/Vast Mtn. It's so far fetched, it's absolutely laughable.

These wild assumptions being made are done for one reason and one reason only! TO GET YOU TO SELL BASED ON THEIR ASSUMPTIONS & THEIR CONCLUSIONS! Some will fall for it, mostly those who haven't done their DD or stayed current with the FACTS , especially the FACTS regarding the SPA Agreement w/HSVW and the FACT that CDNL received to date $1.1 million dollars from HSVW, that was used to pay off debts and for other business purposes to move the company forward. Their is a specific clause regarding CDNL BUYING BACK SHARES that is being forgotten.

The only thing that has frustrated many of us, has been the audit, which has prevented the release of updated financials to get the company current. Yes, been many assumptions around that too, but the FACT remains they are not allowed to release updated fins until the audit is completed. The FACT that it has taken so long is directly related to the CEO's very poor accounting abilities before hiring a CFO. That mess he created is taking a long time to wade through, since it involves international business transactions that need to be verified, which take considerable time to complete.

THE FACT IS WE SEE THESE KINDS OF ATTACKS, BASED UPON ASSUMPTIONS NOT FACTS, ALL THE TIME WHEN A COMPANY IS IN A WAIT MODE! Rest assured, these attacks will only increase, in an effort to get YOU to sell so THEY can benefit in some way. Some want a good buy back in price, some want revenge, while others have incentives to directly profit from the fall in the share price.

It's FACTS vs ASSUMPTIONS, and it is up to each to separate the two to arrive at YOUR OWN CONCLUSIONS! Cheers!

PS: I added another 500k @ $.0073 last Friday: https://twitter.com/crookedneck/status/779390595085262848 I WALK THE TALK!

Cardinal Resources, Inc. (CDNL) Stock Research Links

CDNL Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Clover's RSV Combo Vaccine Shows Promise in Trials

Updated Category News Views 4

In the biotech world, there's always a race. Clover Biopharmaceuticals is making strides with their RSV+hMPV vaccine candidate, especially for the elderly. Imagine those big leaps in development—all boosted by recent results from a Phase 2 trial down under in Australia. Key Findings of the Trial Immunogenicity Insights They're not messing around with these findings. The...

Continue Reading
Asia-Pacific Media Forum Eyes Future Growth Strategies

Updated Category News Views 3

Media Heavyweights Converge in Shenzhen Picture this: Over 400 media moguls from the Asia-Pacific region, huddled together in Shenzhen under that blazing September sun. What for? They're on a mission, inspecting China's shifting landscape, hunting down fresh growth avenues in the Guangdong-Hong Kong-Macao Greater Bay Area. It kicks off within the walls of the Asia-Pacific...

Continue Reading
TCL’s AI Vision: Immersive Living at IFA 2026

Updated Category News Views 3

AI and Displays: A Match Made in Tech Heaven Every so often, a company stands up at a tech fair and gives a glimpse into the next chapter of living, as TCL did at IFA 2026. This time, they're not just talking about screens; they're weaving them into the fabric of everyday life alongside AI capabilities. From sporting arenas to your living room, it's a vision of what could...

Continue Reading
MERACH Unveils W60 Plus: A Game Changer for Home Fitness

Updated Category News Views 1

MERACH's Ambitious Leap into European Markets Walking is one of life's simple pleasures, but it's not always convenient in our work-from-home driven world. That's where MERACH's UltraWalk W60 Plus comes in, dropping anchor in Europe like a brand new ship with all the bells and whistles. What makes this walking pad different, you ask? It's designed to become a natural...

Continue Reading
BYD's Chip Mastery Amid China's Auto Supply Tensions

Updated Category News Views 2

Chips, the New Battleground in Automotive Innovation Here we are, folks, knee-deep in a tech-driven car revolution where semiconductors aren't just the icing on the cake—they're the cake itself. As vehicles morph into veritable computers on wheels, reliance on chips is hitting a fever pitch. FYI, it's not just about making cars go; we're talking power management,...

Continue Reading
Aroa Biosurgery Reports Low Infection Rates: A Milestone

Updated Category News Views 2

Peer-Reviewed Study: Aroa's Myriad Shows Low Infection Rates Seems like the folks at Aroa Biosurgery have got something solid to brag about in the world of complex soft tissue reconstruction. The company just released interim results from their massive MASTRR Registry study, and the numbers are looking pretty darn promising. We're talking about a 411-patient analysis...

Continue Reading
Park Systems Expands in the Pacific Northwest

Updated Category News Views 5

Strategic Move into Hillsboro Sparks Industry Buzz Park Systems, already a heavyweight in the nanometrology arena, just made a bold play with the opening of its latest regional office. Nestled in the tech-centric town of Hillsboro, Oregon, this hub is set to redefine how they handle technical support and customer management across the Pacific Northwest. It's like they're...

Continue Reading
ATTACK SHARK Partners with Cloud9 League Team

Updated Category News Views 2

Shaking Hands with Cloud9 ATTACK SHARK is jumping headfirst into the esports game, teaming up with Cloud9's League of Legends team. Now, before you roll your eyes at another corporate matchmaking play, consider the magic at play here. League of Legends isn't just any game; it's a titan in the esports universe, and partnering with Cloud9 offers a serious boost. It's not...

Continue Reading
D-Wave Hit with Legal Scrutiny After Disappointing Q2

Updated Category News Views 4

D-Wave Quantum Under Legal Microscope Alright, folks, let's dive headfirst into some dicey financial waters with D-Wave Quantum Inc. (NASDAQ: QBTS). This quantum computing company is finding itself in a bit of a pickle following some rough second-quarter results that left investors scratching their heads. If you bought into the hype and are feeling the sting in your...

Continue Reading
Bad Bunny Super Bowl Halftime Show Sweeps 7 Emmy Wins

Updated Category News Views 6

An Unprecedented Performance: A Halftime Show for the Ages Hold onto your hats, folks—Bad Bunny and his Super Bowl LX Halftime Show have taken home a jaw-dropping seven Emmys at the 78th Emmy Awards. This is uncharted territory for any Super Bowl Halftime Show. Never before has a halftime spectacle swept the Emmys like this. We’re talking about categories such as...

Continue Reading

Top 5 Most Recently Viewed Articles

Genentech's Itovebi Shows Promising Survival Rates in Cancer

Updated Category News Views 123

Genentech's Itovebi Shows Significant Progress in Cancer Treatment Genentech, a member of the Roche Group (OTCQX: RHHBY), has made headlines with their recent announcement regarding the positive results from the Phase III INAVO120 study focused on Itovebi (inavolisib). This study investigates the combination of Itovebi, palbociclib (Ibrance), and fulvestrant for...

Continue Reading
Exploring the Recent Options Trends for AST SpaceMobile (ASTS)

Updated Category News Views 252

Understanding the Recent Options Activity of AST SpaceMobile Recent market patterns indicate that some investors are taking a bearish stance on AST SpaceMobile (NASDAQ: ASTS). This noteworthy behavior is significant for retail traders to consider as shifts in investor sentiment can often hint at future market movements. Generally, when large trades appear, it suggests...

Continue Reading
Foresight Financial Reports Significant Growth in Q3 Results

Updated Category News Views 41

Impressive Growth in Third Quarter Results Foresight Financial Group, Inc., a multi-bank holding company based in Northern Illinois, has announced remarkable financial results for the third quarter. Net income surged by an impressive 33.3%, rising to $3,396,000 from $2,547,000 recorded the previous year. This significant increase is attributable to a decrease in...

Continue Reading
Certara and Ichnos Glenmark Partnership Advances Cancer Treatment

Updated Category News Views 173

Enhancing Cancer Treatment Through Collaborative Innovation Certara, Inc. (NASDAQ: CERT), headquartered in Radnor, Pennsylvania, is leading the way in model-informed drug development. The company recently shared encouraging results from their partnership with Ichnos Glenmark Innovation (IGI), focusing on improving the dosing strategy for ISB 2001, a promising candidate in...

Continue Reading
InventHelp Unveils Innovative Compact Backup Footwear Solution

Updated Category News Views 133

Revolutionizing On-the-Go Footwear Solutions In today's fast-paced world, having the right gear at your fingertips is essential. An inventive individual from Silverlake, with a desire to enhance comfort in our daily lives, has brought forth a remarkable idea for a compact spare pair of shoes known as BETTER THAN BAREFOOT (B T B). The goal behind this innovation is simple...

Continue Reading